Advertisement

Malignancy of Glioma Estimated by PET-18F-FDG, PET-11C-Methionine, and SPECT-201Thallium

  • Masaru Tamura
  • Takashi Shibasaki
  • Satoru Horikoshi
  • Noboru Oriuchi

Abstract

The detection of malignancy in glioma by histological studies and by the bromodeoxyuridine labeling index (BUdR-LI) have been well documented [1]. Increased glucose and amino acid uptake in glioma measured by positron emission tomography (PET) with fluorine-18-fluorodeoxyglucose (FDG) [2] and with carbon-11-methionine (Met) [3] have been reported capable of identifying the malignant grade of lesions. Single photon emission CT (SPECT) with 201-thalium chloride (Tl) is also valuable for determining the grade of malignancy [4]. A method of predicting malignancy preoperatively could alert the operating surgeon to the extent of tumor removal that will be required.

Keywords

Positron Emission Tomography Malignant Glioma Tumor Region Medial Temporal Lobe Pilocytic Astrocytoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Hoshino T, Nagashima T, Murovic JA, Wilson CB, Edwards MSB, Gutin PH, Davis RL, DeArmond SJ (1986) In situ cell kinetics studies on human neuroectodermal tumors with bromodeoxyuridine labeling. J Neurosurg 64: 453–459PubMedCrossRefGoogle Scholar
  2. 2.
    Di Chiro G, DeLaPaz RL, Brooks RA, Sokoloff L, Kornblith PL, Smith BH, Patronas NJ, Kufta CV, Kessler RM, Johnston GS, Manning RG, Wolf AP (1982) Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography. Neurology 32: 1323–1329PubMedGoogle Scholar
  3. 3.
    Ericson K, Lilja A, Bergstrom M, Collins VP, Eriksson L, Ehrin E, von Hoist H, Lundqvist H, Langstrom B, Mosskin M (1985) Positron emission tomography with ([nC]methyl)-L-methionine, [11C] D-glucose, and [68Ga] EDTA in supratentorial tumors. J Comput Assist Tomogr 9: 683–689PubMedCrossRefGoogle Scholar
  4. 4.
    Black KL, Hawkins RA, Kim KT, Becker DP, Lerner C, Marciano D (1989) Use of thalium-201 SPECT to quantitate malignancy grade of gliomas. J Neurosurg 71: 342–346PubMedCrossRefGoogle Scholar
  5. 5.
    Araki Y, Imano Y, Hirata T, Andoh T, Sakai N, Yamada H (1989) Thalium-201 imaging of brain tumors using single photon emission CT (in Japanese). Kaku Igaku (Jpn J Nucl Med) 26: 1363–1369Google Scholar
  6. 6.
    Shishido F, Uemura K, Inugami A, Tomura N, Higano S, Fujita H, Murakami M, Kanno I, Yasui N, Mineura K (1990) Value of 11C-methionine and PET in the diagnosis of low-grade gliomas (in Japanese). Kaku Igaku (Jpn J Nucl Med) 27: 239–302.Google Scholar

Copyright information

© Springer-Verlag Tokyo 1991

Authors and Affiliations

  • Masaru Tamura
    • 1
  • Takashi Shibasaki
    • 1
  • Satoru Horikoshi
    • 1
  • Noboru Oriuchi
    • 2
  1. 1.Department of NeurosurgeryGunma University School of MedicineMaebashi, 371Japan
  2. 2.Nuclear MedicineGunma University School of MedicineMaebashi, 371Japan

Personalised recommendations